128 related articles for article (PubMed ID: 1973719)
41. Effect of Graves' intrathyroidal lymphocytes. Effect of Graves' disease intrathyroidal lymphocytes (ITL) on xenotransplants of human thyroid tissue in athymic nude mice.
Schumm-Draeger PM; Jungheim K; Caspar G; Hermann G; Fortmeyer HP; Wenisch HJ; Usadel KH
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():60-3. PubMed ID: 8981004
[TBL] [Abstract][Full Text] [Related]
42. Methimazole has no dose-related effect on the intensity of the intrathyroidal autoimmune process in relapsing Graves' disease.
Paschke R; Vogg M; Kristoferitsch R; Aktuna D; Wawschinek O; Eber O; Usadel KH
J Clin Endocrinol Metab; 1995 Aug; 80(8):2470-4. PubMed ID: 7629244
[TBL] [Abstract][Full Text] [Related]
43. Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease.
Grubeck-Loebenstein B; Londei M; Greenall C; Pirich K; Kassal H; Waldhäusl W; Feldmann M
J Clin Invest; 1988 May; 81(5):1608-14. PubMed ID: 3130398
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical characterization of intrathyroid lymphocytes in Graves' disease. Interstitial and intraepithelial populations.
Margolick JB; Hsu SM; Volkman DJ; Burman KD; Fauci AS
Am J Med; 1984 May; 76(5):815-21. PubMed ID: 6372453
[TBL] [Abstract][Full Text] [Related]
45. Non-polarized cell surface expression of HLA-A,B,C and HLA-DR antigens in Graves' thyroid follicle cells.
Mölne J; Nilsson M; Jansson S; Hansson G; Ericson LE
Autoimmunity; 1991; 10(3):189-99. PubMed ID: 1756224
[TBL] [Abstract][Full Text] [Related]
46. The effect of adding a surfeit of autologous CD8+ T cells to SCID mice after secondary rexenografts of Graves' thyroid tissue.
Mukuta T; Nishikawa M; Arreaza G; Resetkova E; Yoshikawa N; Fornasier V; Young E; Volpé R
Thyroid; 1996 Oct; 6(5):429-36. PubMed ID: 8936667
[TBL] [Abstract][Full Text] [Related]
47. Intrathyroidal T cell clones from patients with autoimmune thyroid disease.
MacKenzie WA; Schwartz AE; Friedman EW; Davies TF
J Clin Endocrinol Metab; 1987 Apr; 64(4):818-24. PubMed ID: 2880865
[TBL] [Abstract][Full Text] [Related]
48. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM
J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
[TBL] [Abstract][Full Text] [Related]
49. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
Resetkova E; Kawai K; Enomoto T; Arreaza G; Togun R; Foy TM; Noelle RJ; Volpé R
Thyroid; 1996 Aug; 6(4):267-73. PubMed ID: 8875745
[TBL] [Abstract][Full Text] [Related]
50. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
Chan JY; Walfish PG
Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
[TBL] [Abstract][Full Text] [Related]
51. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
[TBL] [Abstract][Full Text] [Related]
52. Demonstration of circulating immune complexes in Graves' disease by the Raji cell technique and their relation to different thyroid autoantibodies.
Hopf U; Hütteroth TH; Kotulla P
Horm Metab Res; 1979 Nov; 11(11):622-8. PubMed ID: 231561
[No Abstract] [Full Text] [Related]
53. CD4+CD45RA+ cells (suppressor-inducer T cells) in thyroid tissue from patients with Graves' disease.
Kawakami A; Eguchi K; Matsunaga M; Tezuka H; Ueki Y; Shimomura C; Otsubo T; Nakao H; Migita K; Ishikawa N
Acta Endocrinol (Copenh); 1991 Dec; 125(6):687-93. PubMed ID: 1838659
[TBL] [Abstract][Full Text] [Related]
54. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
55. Studies on the immunoregulation of thyroid autoantibody production in vitro.
Benveniste P; Row VV; Volpé R
Clin Exp Immunol; 1985 Aug; 61(2):274-82. PubMed ID: 2412743
[TBL] [Abstract][Full Text] [Related]
56. The influence of iodine on the intensity of the intrathyroidal autoimmune process in Graves' disease.
Paschke R; Vogg M; Winter J; Wawschinek O; Eber O; Usadel KH
Autoimmunity; 1994; 17(4):319-25. PubMed ID: 7948614
[TBL] [Abstract][Full Text] [Related]
57. Changes in serum thyroglobulin and thyroid autoantibodies in patients with Graves' disease treated with antithyroid drug and their relationship to relapse.
Gong ST; Chao IM
J Formos Med Assoc; 1991 Dec; 90(12):1155-62. PubMed ID: 1724781
[TBL] [Abstract][Full Text] [Related]
58. The remarkable proliferation of helper T cell subset in response to autologous thyrocytes and intrathyroidal T cells from patients with Graves' disease.
Eguchi K; Otsubo T; Kawabe Y; Ueki Y; Fukuda T; Matsunaga M; Shimomura C; Ishikawa N; Tezuka H; Nakao H
Clin Exp Immunol; 1987 Nov; 70(2):403-10. PubMed ID: 2962792
[TBL] [Abstract][Full Text] [Related]
59. The regulatory role of human helper T-cell clones on antithyroid antibody production by peripheral B-cells.
Fisfalen ME; Soltani K; Janiga AM; Kawakami Y; Macchia E; Quintans J; DeGroot LJ
J Clin Endocrinol Metab; 1990 Jul; 71(1):170-8. PubMed ID: 1695223
[TBL] [Abstract][Full Text] [Related]
60. Self-tolerance and autoimmunity in the thyroid.
Allison AC
N Engl J Med; 1976 Oct; 295(15):821-7. PubMed ID: 183115
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
